IMUX · Immunic Inc
United States · RS rating 42 · As of 2026-11-03
| Price | 7.60 USD |
|---|---|
| 1-day change | +3.5% |
| RS rating (overall / 1M / 3M / 12M) | 42 / 43 / 11 / 99 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 27 / 33 / 44 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +25.9% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +55.0% |
| Market cap (USD) | $125.1M |